Skip to main content
. Author manuscript; available in PMC: 2020 May 12.
Published in final edited form as: Curr Eye Res. 2018 Oct 19;44(3):264–274. doi: 10.1080/02713683.2018.1533983

Table 2.

Characteristics of aflibercept release.

DDS formulation Drug total load amount (μg) Initial burst release (μg) Release rate after 7 days (μg/day) Release time (days) Final percent release (%)
2 mM DDS-10 99.45 ± 10.06 37.35 ± 4.92 0.11(r2 = 0.92) 204 66.56 ± 1.35
2 mM DDS-20 193.93 ± 5.56 74.03 ± 8.23 0.15(r2 = 0.95) 204 61.84 ± 2.31
3 mM DDS-10 98.70 ± 4.81 38.62 ± 2.78 0.07(r2 = 0.94) 204 70.02 ± 1.91
3 mM DDS-20 190.72 ± 7.77 74.56 ± 6.16 0.14(r2 = 0.97) 204 66.78 ± 1.56